411 related articles for article (PubMed ID: 12697936)
41. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.
Chen G; Chen KS; Knox J; Inglis J; Bernard A; Martin SJ; Justice A; McConlogue L; Games D; Freedman SB; Morris RG
Nature; 2000 Dec 21-28; 408(6815):975-9. PubMed ID: 11140684
[TBL] [Abstract][Full Text] [Related]
42. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
[TBL] [Abstract][Full Text] [Related]
43. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
[TBL] [Abstract][Full Text] [Related]
44. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
[TBL] [Abstract][Full Text] [Related]
45. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
[TBL] [Abstract][Full Text] [Related]
46. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
[TBL] [Abstract][Full Text] [Related]
47. Intrahippocampal injections of the beta-amyloid 1-28 fragment induces behavioral deficits in rats.
Alvarez XA; Miguel-Hidalgo JJ; Fernández-Novoa L; Cacabelos R
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):471-9. PubMed ID: 9413830
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
[TBL] [Abstract][Full Text] [Related]
49. Alzheimer's disease: genesis of amyloid.
Beyreuther K; Multhaup G; Masters CL
Ciba Found Symp; 1996; 199():119-27; discussion 127-31. PubMed ID: 8915607
[TBL] [Abstract][Full Text] [Related]
50. Extracellular amyloid-beta and cytotoxic glial activation induce significant entorhinal neuron loss in young PS1(M146L)/APP(751SL) mice.
Moreno-Gonzalez I; Baglietto-Vargas D; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Del Rio JC; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
J Alzheimers Dis; 2009; 18(4):755-76. PubMed ID: 19661615
[TBL] [Abstract][Full Text] [Related]
51. Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein.
Cha JH; Farrell LA; Ahmed SF; Frey A; Hsiao-Ashe KK; Young AB; Penney JB; Locascio JJ; Hyman BT; Irizarry MC
Neurobiol Dis; 2001 Feb; 8(1):90-102. PubMed ID: 11162243
[TBL] [Abstract][Full Text] [Related]
52. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice.
Lazarov O; Lee M; Peterson DA; Sisodia SS
J Neurosci; 2002 Nov; 22(22):9785-93. PubMed ID: 12427834
[TBL] [Abstract][Full Text] [Related]
53. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
54. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
D'Andrea MR; Nagele RG
Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391
[TBL] [Abstract][Full Text] [Related]
55. High-throughput quantitative histological analysis of Alzheimer's disease pathology using a confocal digital microscanner.
Hanzel DK; Trojanowski JQ; Johnston RF; Loring JF
Nat Biotechnol; 1999 Jan; 17(1):53-7. PubMed ID: 9920269
[TBL] [Abstract][Full Text] [Related]
56. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model.
Jeong YH; Park CH; Yoo J; Shin KY; Ahn SM; Kim HS; Lee SH; Emson PC; Suh YH
FASEB J; 2006 Apr; 20(6):729-31. PubMed ID: 16467370
[TBL] [Abstract][Full Text] [Related]
57. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
[TBL] [Abstract][Full Text] [Related]
58. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
59. Multiphoton microscopy and amyloid angiopathy.
Christie R; Kimchi E; Kajdasz S; Bacskai B; Hyman BT
Amyloid; 2001 Jul; 8 Suppl 1():48-50. PubMed ID: 11676290
[TBL] [Abstract][Full Text] [Related]
60. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease.
Ryoo HL; Joyce JN
J Comp Neurol; 1994 Oct; 348(1):94-110. PubMed ID: 7814686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
